- You can view the full Medtronic Ratings Report.
- Use our health services section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Medtronic ( MDT) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day up 0.4%. By the end of trading, Medtronic fell $0.62 (-1.2%) to $52.81 on average volume. Throughout the day, 3,579,639 shares of Medtronic exchanged hands as compared to its average daily volume of 4,562,100 shares. The stock ranged in price between $52.76-$53.48 after having opened the day at $53.46 as compared to the previous trading day's close of $53.43. Other companies within the Health Services industry that declined today were: Abiomed ( ABMD), down 7.4%, Baxter International ( BAX), down 6.4%, Spherix ( SPEX), down 5.7% and Navidea Biopharmaceuticals ( NAVB), down 5.6%. Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. The company operates in two segments, Cardiac and Vascular Group, and Restorative Therapies Group. Medtronic has a market cap of $53.6 billion and is part of the health care sector. Shares are up 31.1% year to date as of the close of trading on Tuesday. Currently there are 6 analysts that rate Medtronic a buy, no analysts rate it a sell, and 12 rate it a hold. TheStreet Ratings rates Medtronic as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, increase in net income and reasonable valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow.
